The UK's medicines regulator has warned NHS healthcare staff about an increased risk of a condition affecting the nerves in ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

The medicines regulator has issued a warning to NHS health staff about a small increased risk of a rare condition affecting ...

European Commission President Ursula von der Leyen faces a rare no-confidence vote in the European Parliament this week.

After several PD-1xVEGF competitors forged alliances with Big Pharma players, Summit Therapeutics, the frontrunner in this hot cancer drug field, is reportedly seeking its own deal. | After several PD ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sustainable change requires improved study design, market incentives, and patient involvement, write Kate Womersley and colleagues For too long, medical research has defaulted to male physiology, ...

Despite representing only 4% of the world’s population, the United States accounts for over half of science Nobel Prizes ...

The Cyprus issue, water scarcity issues and forest fires in the EU and developments in the Middle east will be among the ...

Health officials have highlighted a rise in incidents of Covid-19 on the island, in the wake of an alert issued by the ...

Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...